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a b s t r a c t 
The contribution of neurological symptomatology to morbidity and mortality after infection 
with Severe Acute Respiratory Syndrome-associated Coronavirus (SARS CoV II) is ill-defined. 
We hereby present a case of a 57-year old male patient, in excellent physical condition, 
who was admitted to the Intensive Care Unit (ICU), with respiratory distress duo to SARS 
CoV II-induced bilateral pneumonia. After 2 weeks at the ICU, with respiratory conditions 
improving, the patient developed lethal cerebral edema. This case advocates regular wake- 
up calls in Coronavirus disease 2019 patients for neurological (radiological) evaluation to 
provide rapid diagnosis and a therapeutic window for fulminant central nervous system 
complications. 
© 2020 The Authors. Published by Elsevier Inc. on behalf of University of Washington. 
This is an open access article under the CC BY-NC-ND license. 





















In December 2019, human infection with a newly identified
Severe Acute Respiratory Syndrome-associated Coronavirus
(SARS CoV) was first reported from Wuhan, China [1] . In the
spring of 2020, the world witnessed a major outbreak of the
virus which causes Coronavirus disease 2019 (COVID-19). With
the continuing SARS CoV 2 epidemic, Intensive Care Units
(ICU) around the world face a substantial increase in patients
requiring ventilatory support. Morbidity and mortality due to∗ Corresponding author. 
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CC BY-NC-ND license. ( http://creativecommons.org/licenses/by-nc-nd/COVID-19 is largely attributed to respiratory distress after on-
set of bilateral pneumonia. The contribution of the nonrespi-
ratory symptomatology of COVID-19 to prognosis is currently
unclear. As shown by a recent case series, the presenting
symptomatology of an infection with SARS CoV II can include
gastrointestinal symptoms, eg, diarrhea or vomiting, as well
as neurological manifestations including headache, anosmia,
and dizziness [2-4] . While recent editorials call for enhanced
clinical concern for central nervous system (CNS) pathology
within the course of SARS CoV 2 infection, a direct correlation
between an infection with this viral agent and neurological). 
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Fig. 1 – Chest X-ray on admission showing bilateral 












































morbidity remains unclear [5-7] . We present a case of exten-
sive cerebral edema in an ICU patient with hypoxic respiratory
distress, caused by COVID-19 bilateral pneumonia. 
Case report 
On March 18, 2020 a 57-year-old male presented to our hospi-
tal. His medical history noted hypertension and his body mass
index was 28 kg/m 2 . He was in an excellent physical condition
and was regular swimmer. The patient developed fatigue and
fever after a trip to Austria on March 9. Over the course of a few
days his symptoms worsened with dyspnea, nausea, vomiting,Fig. 2 – Transversal cerebral CT scan showing extensive vasogen
stem with obliteration of basal cerebral cisterns. and diarrhea. He presented at the emergency department with
acute respiratory distress, with tachypnea (40 breaths/min),
arterial desaturation (88%), and an arterial blood gas analysis
with a p a O 2 level of 47 mm Hg. Oxygen therapy was admin-
istered using a nonrebreathing mask. Chest X-ray showed
diffuse bilateral infiltrates ( Fig. 1 ) and polymerase chain reac-
tion on a nasopharyngeal swab tested positive for SARS CoV
2. Inflammatory parameters on admission were high, with
C-reactive protein (CRP) of 303 mg/L (reference range: 0-10
mg/L) and white-cell count of 10.2 × 10 9 /L (reference range: 4-
10 × 10 9 /L). On admission to the ICU, the patient was immedi-
ately intubated for respiratory failure due to Acute Respiratory
Distress Syndrome (ARDS). He also developed acute kidney
injury for which continuous renal replacement therapy was
initiated. After 7 days on the ICU, a CT scan of the thorax was
indicated as the ARDS persisted, showing bilateral pulmonary
emboli despite prophylaxis with low-molecular weight hep-
arin (LMWH). Therapeutic LMWH was subsequently started
(10.000IE, twice daily) instead of prophylactic dosage. During
the first 2 weeks of ICU admission the patient was managed
on mechanical ventilation requiring high dosages of sedatives
(midazolam) and intermittent neuromuscular blockade with
rocuronium. Intermittent prone positioning was done during
the first week of admission. The clinical course was further
characterized by hemodynamic stability, requiring low dose
norepinephrine. Lactate levels remained normal. During the
second week, respiratory condition markedly improved as
indicated by improved p a O 2 /f i O 2 ratio, and ventilator set-
tings improved to assisted-breathing and sedatives could
tapered. On day 15, approximately 24 hours after midazolam
sedation had been stopped, dilated and nonreactive pupils
were noted on physical examination. An emergency CT scan
and CT angiography of the brain showed extensive cerebral
edema and brain herniation ( Figs. 2 and 3 ). Several subcortical
hemorrhages were present without focal areas of arterialic edema and herniation of temporal lobes toward the brain 
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Fig. 3 – Transversal cerebral CT scan showing extensive vasogenic edema with effacement of ventricles and peripheral sulci 
and gyri. 
















infarction ( Fig. 4 ). CT angiography showed absence of cerebral
perfusion distally from the internal carotid arteries. The
patient had remained in a hypercoagulable state, despite
the administration of therapeutic dosages of LMWH, as was
confirmed by thromboelastometry (Supplementary Fig. 1)
with a modestly elevated fibrinogen level of 5.7 g/L (reference
range: 2.0-4.0 g/L). Partial thromboplastin time was normal
and activated partial thromboplastin time was 25 seconds
(reference range: 25-31 seconds). Brain stem reflexes on sub-
sequent clinical neurological examination were absent. Given 
the infaust prognosis, further treatment was considered futile
and the patient died shortly afterward. The patient’s relatives
granted consent for publication of his case, autopsy was not
performed. 
Discussion 
The observed signs and symptoms of COVID-19, likely due to
a direct inflammatory response in the respiratory tract, in-










































clude cough, dyspnea and fever. SARS CoV infections target
the angiotensin-converting enzyme 2 receptor and thereby
gain entry to the human body to replicate [8] . During earlier
coronavirus outbursts, including during the Middle East res-
piratory syndrome coronavirus outbreak in 2012, reports have
been published on coronavirus spreading to the CNS by di-
rectly infestation of the CNS [9-12] . Several hypotheses on CNS
infiltration have been formulated, including viral transmis-
sion from the nasal cavity via the olfactory nerve [13] , but a
recent report did not find direct viral CNS entry [14] . We hereby
present a case of massive and rapidly fatal cerebral edema
in a patient who was admitted to the ICU with severe ARDS
due to COVID-19. In this case, the absence of histopathologi-
cal evidence or cerebrospinal fluid analysis complicates deter-
mination of a certain diagnosis. The differential diagnosis in
this case includes: (massive) cerebral venous sinus thrombo-
sis, hemorrhagic/necrotizing (viral) encephalitis (and thereby
developing reactive cerebral edema) and (massive) vasculi-
tis [15] . SARS CoV 2 is the latest descendent in the strain of
coronaviruses, with prior fellow species suggested to (directly)
cause necrotizing encephalitis. CT scan showed multiple jux-
tacortical hemorrhages ( Fig. 4 ), which may well fit the diag-
nosis of cranial sinus thrombosis. Remarkably, cortex involve-
ment was limited, making arterial infarction less suspect as
a cause for cerebral vasogenic edema. Of note, hypercoag-
ulability in COVID-19 has recently been well described and
was present in this patient despite treatment with therapeutic
LMWH [16] . 
Conclusion 
Details of CNS manifestations of COVID-19 caused by SARS
CoV 2 infection are ill-defined and uncertain. However, based
on clinical observations and research on prior coronaviruses,
the potential of SARS CoV 2 to involve CNS tissue should
be considered. The course of events in this case advocates
wake-up calls on a regular basis to evaluate cerebral func-
tion and to consider thorough neurological evaluation, in-
cluding CT angiography. In this case earlier detection might
have been possible and therapeutic options could have the-
oretically included endovascular thrombectomy for cere-
bral venous sinus thrombosis or corticosteroids for cerebral
vasculitis. 
Supplementary materials 
Supplementary material associated with this article can
be found, in the online version, at doi: 10.1016/j.radcr.2020.
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